David Burrow, Director of the FDA’s Office of Scientific Investigations (CDER), as he shares the agency’s outlook on advancing clinical trials through the Center for Clinical Trial Innovation (C3TI).
David Burrow, Director of the FDA’s Office of Scientific Investigations (CDER), as he shares the agency’s outlook on advancing clinical trials through the Center for Clinical Trial Innovation (C3TI).